Suspected Recurrence of Symptomatic COVID-19: Management During Inpatient Psychiatric Treatment.
J Psychiatr Pract
; 27(2): 137-144, 2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1292182
ABSTRACT
The widespread prevalence of coronavirus disease 2019 (COVID-19) means that inpatient psychiatric units will necessarily manage patients who have COVID-19 that is comorbid with acute psychiatric symptoms. We report a case of recurrence of respiratory symptoms and positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) testing in a patient on an inpatient psychiatric unit occurring 42 days after the initial positive SARS-CoV-2 RT-PCR test, 38 days after initial symptom resolution, and 30 days after the first of 3 negative SARS-CoV-2 RT-PCR tests. Over the course of the admission, the patient was safely initiated on clozapine. Recent literature on COVID-19's potential recurrence and neuropsychiatric effects is reviewed and implications for the management of COVID-19 on inpatient psychiatric units are discussed. In the era of COVID-19 and our still-developing understanding of this illness, psychiatrists' role as advocates and collaborators in our patients' physical health care has become even more critical.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Trastornos Psicóticos
/
Antipsicóticos
/
Trastorno Depresivo Mayor
/
COVID-19
/
Antidepresivos
Tipo de estudio:
Reporte de caso
/
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
/
Investigación cualitativa
Tópicos:
Covid persistente
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
J Psychiatr Pract
Asunto de la revista:
Psiquiatria
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS